Mettler-Toledo International MTD
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-12T02:43:51.232Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:00:00.002360428Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:43:50.522971+00:00
Mettler-Toledo International options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 1825.04 | 30.4% | 4.9% | 1679.13 | 32.5% | 4.6% |
| 25Δ | 1809.79 | 30.1% | 4.2% | 1701.39 | 27.9% | 3.4% |
| 30Δ | 1797.32 | 30.4% | 3.7% | 1711.46 | 28.7% | 3.0% |
| 35Δ | 1784.93 | 29.9% | 3.1% | 1721.59 | 29.4% | 2.7% |
| 40Δ | 1773.64 | 29.8% | 2.7% | 1732.09 | 29.3% | 2.3% |
| 45Δ | 1763.08 | 29.9% | 2.4% | 1742.46 | 29.1% | 2.0% |
| 50Δ | 1752.56 | 30.4% | 2.1% | 1752.48 | 29.0% | 1.7% |
| 55Δ | 1742.04 | 31.0% | 1.8% | 1762.54 | 28.8% | 1.4% |
| 60Δ | 1730.92 | 31.3% | 1.5% | 1772.69 | 28.7% | 1.2% |
| 65Δ | 1719.62 | 31.6% | 1.3% | 1782.72 | 28.3% | 0.9% |
| 70Δ | 1706.99 | 32.0% | 1.1% | 1792.44 | 27.4% | 0.7% |
| 75Δ | 1692.86 | 32.7% | 0.9% | 1803.26 | 26.9% | 0.5% |
| 80Δ | 1676.78 | 33.6% | 0.7% | 1817.94 | 27.7% | 0.4% |
20Δ
- Pseudo strike
- 1825.04
- IV
- 30.4%
- B/E move
- 4.9%
- Pseudo strike
- 1679.13
- IV
- 32.5%
- B/E move
- 4.6%
25Δ
- Pseudo strike
- 1809.79
- IV
- 30.1%
- B/E move
- 4.2%
- Pseudo strike
- 1701.39
- IV
- 27.9%
- B/E move
- 3.4%
30Δ
- Pseudo strike
- 1797.32
- IV
- 30.4%
- B/E move
- 3.7%
- Pseudo strike
- 1711.46
- IV
- 28.7%
- B/E move
- 3.0%
35Δ
- Pseudo strike
- 1784.93
- IV
- 29.9%
- B/E move
- 3.1%
- Pseudo strike
- 1721.59
- IV
- 29.4%
- B/E move
- 2.7%
40Δ
- Pseudo strike
- 1773.64
- IV
- 29.8%
- B/E move
- 2.7%
- Pseudo strike
- 1732.09
- IV
- 29.3%
- B/E move
- 2.3%
45Δ
- Pseudo strike
- 1763.08
- IV
- 29.9%
- B/E move
- 2.4%
- Pseudo strike
- 1742.46
- IV
- 29.1%
- B/E move
- 2.0%
50Δ
- Pseudo strike
- 1752.56
- IV
- 30.4%
- B/E move
- 2.1%
- Pseudo strike
- 1752.48
- IV
- 29.0%
- B/E move
- 1.7%
55Δ
- Pseudo strike
- 1742.04
- IV
- 31.0%
- B/E move
- 1.8%
- Pseudo strike
- 1762.54
- IV
- 28.8%
- B/E move
- 1.4%
60Δ
- Pseudo strike
- 1730.92
- IV
- 31.3%
- B/E move
- 1.5%
- Pseudo strike
- 1772.69
- IV
- 28.7%
- B/E move
- 1.2%
65Δ
- Pseudo strike
- 1719.62
- IV
- 31.6%
- B/E move
- 1.3%
- Pseudo strike
- 1782.72
- IV
- 28.3%
- B/E move
- 0.9%
70Δ
- Pseudo strike
- 1706.99
- IV
- 32.0%
- B/E move
- 1.1%
- Pseudo strike
- 1792.44
- IV
- 27.4%
- B/E move
- 0.7%
75Δ
- Pseudo strike
- 1692.86
- IV
- 32.7%
- B/E move
- 0.9%
- Pseudo strike
- 1803.26
- IV
- 26.9%
- B/E move
- 0.5%
80Δ
- Pseudo strike
- 1676.78
- IV
- 33.6%
- B/E move
- 0.7%
- Pseudo strike
- 1817.94
- IV
- 27.7%
- B/E move
- 0.4%
Options history
Table
| Date | IV (%) |
|---|---|
| 35.16% | |
| 35.14% | |
| 35.36% | |
| 36.72% | |
| 36.33% | |
| 36.93% | |
| 37.47% | |
| 37.91% | |
| 37.60% | |
| 39.61% |
Diagnostics & Research
MYGN
Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The…
More →NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
More →NTRA
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
More →OPK
OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and…
More →PSNL
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
More →QGEN
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
More →